![]() Lactation: Use while breastfeeding only if potential maternal benefit justifies potential risk to infant may result in bradycardia, constipation, diarrhea, and dry mouth/skin/eyes in infant, especially in mothers who are CYP2D6 poor metabolizers.OB: Use during pregnancy only if potential maternal benefit justifies potential fetal risk crosses the placenta and may cause fetal/neonatal bradycardia, hypotension, hypoglycemia, or respiratory depression.Untreated pheochromocytoma (initiate only after alpha blocker therapy started).Patients with a history of severe allergic reactions (intensity of reactions may be ↑). ![]() Diabetes mellitus (may mask signs of hypoglycemia).Pulmonary disease (including asthma beta 1 selectivity may be lost at higher doses). ![]() ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |